No results found.
Executive Summary
In a post-pandemic clinical research landscape defined by speed, diversity, and decentralized access, patient recruitment remains the single largest cause of trial delays. Studies show 80–85% of clinical trials fail to meet initial enrollment projections, with nearly 30% of sites enrolling zero patients. Yet in this crisis lies opportunity. The rise of digital health, AI, and patient-first design has triggered a wave of innovation that is reshaping recruitment from the ground up.
This white paper outlines four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
The hybridization of clinical trials has evolved from emergency pandemic response to long-term strategy.
Sites and sponsors must plan for multi-modal enrollment flows—combining remote pre-screening, eConsent, telehealth, and at-home data collection with selective in-person visits. Recruitment strategies that ignore these modalities will be outcompeted in both speed and inclusion.
The days of depending solely on physician referrals and community outreach are over. Patients now expect digital discovery—with 81% starting their health journeys online, per a 2023 Pew Health Survey.
Effective digital recruitment requires more than ad spend—it requires creative science (headline testing, inclusive imagery, culturally adapted messaging), geographic precision, and fast lead response protocols at the site level. Sites that build internal digital fluency or partner with full-service platforms are outperforming their peers.
Artificial Intelligence is no longer experimental in recruitment—it’s functional.
Early-adopting sites are embedding AI into feasibility, eligibility screening, and campaign optimization workflows. But success depends on human-AI integration—technology must serve coordinators, not replace them. AI should be seen as a co-pilot, not an automation shortcut.
“Patient-centric” is no longer a buzzword—it’s a recruitment and retention differentiator.
Sponsors and sites must treat recruitment as a consumer marketing function. That means user testing, plain language, and participant trust-building. It also requires culturally and linguistically tailored outreach—particularly for therapeutic areas with historical mistrust, such as oncology or infectious diseases in BIPOC communities.
2025 marks a turning point. No longer is recruitment just about filling quotas—it’s about precision, equity, and speed. Success will belong to those who can:
Clinical research doesn’t have a patient access problem. It has a strategy alignment problem. The good news? That’s fixable—with the right tools, the right partners, and the willingness to evolve.